The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global POC Diagnostics Market Research Report 2024
Synopsis
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
The global POC Diagnostics market was valued at US$ 25670 million in 2023 and is anticipated to reach US$ 48500 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.
In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.
This report aims to provide a comprehensive presentation of the global market for POC Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Diagnostics.
Report Scope
The POC Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global POC Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Segment by Application
Clinics
Hospitals
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of POC Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
The global POC Diagnostics market was valued at US$ 25670 million in 2023 and is anticipated to reach US$ 48500 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.
In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%.
In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc.
This report aims to provide a comprehensive presentation of the global market for POC Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POC Diagnostics.
Report Scope
The POC Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global POC Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POC Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas or Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
Others
Segment by Application
Clinics
Hospitals
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of POC Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of POC Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 POC Diagnostics Market Overview
1.1 Product Overview and Scope of POC Diagnostics
1.2 POC Diagnostics Segment by Type
1.2.1 Global POC Diagnostics Market Value Comparison by Type (2024-2030)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas or Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 POC Diagnostics Segment by Application
1.3.1 Global POC Diagnostics Market Value by Application: (2024-2030)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Global POC Diagnostics Market Size Estimates and Forecasts
1.4.1 Global POC Diagnostics Revenue 2019-2030
1.4.2 Global POC Diagnostics Sales 2019-2030
1.4.3 Global POC Diagnostics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 POC Diagnostics Market Competition by Manufacturers
2.1 Global POC Diagnostics Sales Market Share by Manufacturers (2019-2024)
2.2 Global POC Diagnostics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global POC Diagnostics Average Price by Manufacturers (2019-2024)
2.4 Global POC Diagnostics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of POC Diagnostics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of POC Diagnostics, Product Type & Application
2.7 POC Diagnostics Market Competitive Situation and Trends
2.7.1 POC Diagnostics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest POC Diagnostics Players Market Share by Revenue
2.7.3 Global POC Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 POC Diagnostics Retrospective Market Scenario by Region
3.1 Global POC Diagnostics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global POC Diagnostics Global POC Diagnostics Sales by Region: 2019-2030
3.2.1 Global POC Diagnostics Sales by Region: 2019-2024
3.2.2 Global POC Diagnostics Sales by Region: 2025-2030
3.3 Global POC Diagnostics Global POC Diagnostics Revenue by Region: 2019-2030
3.3.1 Global POC Diagnostics Revenue by Region: 2019-2024
3.3.2 Global POC Diagnostics Revenue by Region: 2025-2030
3.4 North America POC Diagnostics Market Facts & Figures by Country
3.4.1 North America POC Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America POC Diagnostics Sales by Country (2019-2030)
3.4.3 North America POC Diagnostics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe POC Diagnostics Market Facts & Figures by Country
3.5.1 Europe POC Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe POC Diagnostics Sales by Country (2019-2030)
3.5.3 Europe POC Diagnostics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific POC Diagnostics Market Facts & Figures by Country
3.6.1 Asia Pacific POC Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific POC Diagnostics Sales by Country (2019-2030)
3.6.3 Asia Pacific POC Diagnostics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America POC Diagnostics Market Facts & Figures by Country
3.7.1 Latin America POC Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America POC Diagnostics Sales by Country (2019-2030)
3.7.3 Latin America POC Diagnostics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa POC Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa POC Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa POC Diagnostics Sales by Country (2019-2030)
3.8.3 Middle East and Africa POC Diagnostics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global POC Diagnostics Sales by Type (2019-2030)
4.1.1 Global POC Diagnostics Sales by Type (2019-2024)
4.1.2 Global POC Diagnostics Sales by Type (2025-2030)
4.1.3 Global POC Diagnostics Sales Market Share by Type (2019-2030)
4.2 Global POC Diagnostics Revenue by Type (2019-2030)
4.2.1 Global POC Diagnostics Revenue by Type (2019-2024)
4.2.2 Global POC Diagnostics Revenue by Type (2025-2030)
4.2.3 Global POC Diagnostics Revenue Market Share by Type (2019-2030)
4.3 Global POC Diagnostics Price by Type (2019-2030)
5 Segment by Application
5.1 Global POC Diagnostics Sales by Application (2019-2030)
5.1.1 Global POC Diagnostics Sales by Application (2019-2024)
5.1.2 Global POC Diagnostics Sales by Application (2025-2030)
5.1.3 Global POC Diagnostics Sales Market Share by Application (2019-2030)
5.2 Global POC Diagnostics Revenue by Application (2019-2030)
5.2.1 Global POC Diagnostics Revenue by Application (2019-2024)
5.2.2 Global POC Diagnostics Revenue by Application (2025-2030)
5.2.3 Global POC Diagnostics Revenue Market Share by Application (2019-2030)
5.3 Global POC Diagnostics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alere
6.1.1 Alere Corporation Information
6.1.2 Alere Description and Business Overview
6.1.3 Alere POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alere POC Diagnostics Product Portfolio
6.1.5 Alere Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche POC Diagnostics Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories POC Diagnostics Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson POC Diagnostics Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Corporation Information
6.5.2 Siemens Healthcare Description and Business Overview
6.5.3 Siemens Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Siemens Healthcare POC Diagnostics Product Portfolio
6.5.5 Siemens Healthcare Recent Developments/Updates
6.6 Danaher
6.6.1 Danaher Corporation Information
6.6.2 Danaher Description and Business Overview
6.6.3 Danaher POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Danaher POC Diagnostics Product Portfolio
6.6.5 Danaher Recent Developments/Updates
6.7 Bayer Healthcare
6.6.1 Bayer Healthcare Corporation Information
6.6.2 Bayer Healthcare Description and Business Overview
6.6.3 Bayer Healthcare POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Healthcare POC Diagnostics Product Portfolio
6.7.5 Bayer Healthcare Recent Developments/Updates
6.8 Beckman Coulter
6.8.1 Beckman Coulter Corporation Information
6.8.2 Beckman Coulter Description and Business Overview
6.8.3 Beckman Coulter POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Beckman Coulter POC Diagnostics Product Portfolio
6.8.5 Beckman Coulter Recent Developments/Updates
6.9 Nipro Diagnostics
6.9.1 Nipro Diagnostics Corporation Information
6.9.2 Nipro Diagnostics Description and Business Overview
6.9.3 Nipro Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nipro Diagnostics POC Diagnostics Product Portfolio
6.9.5 Nipro Diagnostics Recent Developments/Updates
6.10 Bio-Rad Laboratories
6.10.1 Bio-Rad Laboratories Corporation Information
6.10.2 Bio-Rad Laboratories Description and Business Overview
6.10.3 Bio-Rad Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bio-Rad Laboratories POC Diagnostics Product Portfolio
6.10.5 Bio-Rad Laboratories Recent Developments/Updates
6.11 Nova Biomedical
6.11.1 Nova Biomedical Corporation Information
6.11.2 Nova Biomedical POC Diagnostics Description and Business Overview
6.11.3 Nova Biomedical POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nova Biomedical POC Diagnostics Product Portfolio
6.11.5 Nova Biomedical Recent Developments/Updates
6.12 BioMerieux
6.12.1 BioMerieux Corporation Information
6.12.2 BioMerieux POC Diagnostics Description and Business Overview
6.12.3 BioMerieux POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BioMerieux POC Diagnostics Product Portfolio
6.12.5 BioMerieux Recent Developments/Updates
6.13 Quidel
6.13.1 Quidel Corporation Information
6.13.2 Quidel POC Diagnostics Description and Business Overview
6.13.3 Quidel POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Quidel POC Diagnostics Product Portfolio
6.13.5 Quidel Recent Developments/Updates
6.14 Helena Laboratories
6.14.1 Helena Laboratories Corporation Information
6.14.2 Helena Laboratories POC Diagnostics Description and Business Overview
6.14.3 Helena Laboratories POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Helena Laboratories POC Diagnostics Product Portfolio
6.14.5 Helena Laboratories Recent Developments/Updates
6.15 OraSure Technologies
6.15.1 OraSure Technologies Corporation Information
6.15.2 OraSure Technologies POC Diagnostics Description and Business Overview
6.15.3 OraSure Technologies POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.15.4 OraSure Technologies POC Diagnostics Product Portfolio
6.15.5 OraSure Technologies Recent Developments/Updates
6.16 Accriva
6.16.1 Accriva Corporation Information
6.16.2 Accriva POC Diagnostics Description and Business Overview
6.16.3 Accriva POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Accriva POC Diagnostics Product Portfolio
6.16.5 Accriva Recent Developments/Updates
6.17 Abaxis
6.17.1 Abaxis Corporation Information
6.17.2 Abaxis POC Diagnostics Description and Business Overview
6.17.3 Abaxis POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Abaxis POC Diagnostics Product Portfolio
6.17.5 Abaxis Recent Developments/Updates
6.18 Chembio Diagnostics
6.18.1 Chembio Diagnostics Corporation Information
6.18.2 Chembio Diagnostics POC Diagnostics Description and Business Overview
6.18.3 Chembio Diagnostics POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Chembio Diagnostics POC Diagnostics Product Portfolio
6.18.5 Chembio Diagnostics Recent Developments/Updates
6.19 Trinity Biotech
6.19.1 Trinity Biotech Corporation Information
6.19.2 Trinity Biotech POC Diagnostics Description and Business Overview
6.19.3 Trinity Biotech POC Diagnostics Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Trinity Biotech POC Diagnostics Product Portfolio
6.19.5 Trinity Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 POC Diagnostics Industry Chain Analysis
7.2 POC Diagnostics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 POC Diagnostics Production Mode & Process
7.4 POC Diagnostics Sales and Marketing
7.4.1 POC Diagnostics Sales Channels
7.4.2 POC Diagnostics Distributors
7.5 POC Diagnostics Customers
8 POC Diagnostics Market Dynamics
8.1 POC Diagnostics Industry Trends
8.2 POC Diagnostics Market Drivers
8.3 POC Diagnostics Market Challenges
8.4 POC Diagnostics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
